Weight Reduction Medicine Market
Global Weight Reduction Medicine Market Size, Share & Trends Analysis Report By Product Type (Prescription And Over The Counter), By Application (Appetite Suppression, Fat Blocking, And Others), And By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies And Online Pharmacies) Forecast 2022-2028
The weight reduction medicine market is anticipated to grow from rate of growth during the forecast period. Weight reduction medicine market is anticipated to grow in the coming years as people are facing obesity issues which is an alarming situation for them. According to WHO, 39% of people in the world above the age of 18 are overweight. Obesity is leading to further health issues like high blood pressure, diabetes, hypertension, and cardiac diseases. It is seen that consumers are getting conscious about their health and are focusing on maintaining a healthy diet chart and getting rid of obesity, which is turn creating a significant scope for the weight reduction medicines. People are getting conscious about healthy eating and physical exercise. Market players in the weight reduction medicine segment are providing low-cost programs which is going to drive a good number of consumers to take this plan. For instance, in June 2021, approval was made by the United States Food and Drug Administration to an injection that will control Chronic weight in adults. The condition should be that there should be only one obesity-related health issue like High blood pressure, high cholesterol level, or type 2 diabetes. Dosage in adults should be 2.4 mg once in a week.
Impact of COVID-19 Pandemic on Global Adaptogen Market
Covid-19 Pandemic has affected every sector of the world in some way. However, there has been a rise in demand for weight reduction medicine as the world witnessed nationwide lockdown. This led to people getting overweight as people were not into physical activities. The pandemic pushed more people to seek treatment for obesity. The drug named Wegovy developed by Novo Nordisk company has experienced remarkable sales growth during the pandemic. Wegovy belongs to a range of new diabetes and obesity drugs known as GLP-1 analogues, which by imitating a gut hormone that stimulates insulin production, lower appetite and increase feelings of fullness in patients. Apart from this, the mobility restriction imposed by the government resulted in people getting stress disorders and obesity issues. Stress and obesity disorders increased significant demand for weight reduction medicines among obese people.
Segmental Outlook
The global weight reduction medicine market is segmented based on product type, application, and distribution channel. Based on product type, the market is segmented into prescription and over-the-counter. Based on the application, the market is sub-segmented into appetite suppression, fat blocking, and others). Based on distribution channels the market is sub-segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. Among these, the online pharmacies segment is going to attain a considerable growth in the coming years. Major reason for this is that online platforms provide consumers with hassle free buying options. They get medicines at their doorstep if they are not in position to go out or are in some emergency.
Global Weight Reduction Medicine Market share by Product 2021 (%)
Prescription Drugs are Anticipated to Hold a Prominent Share in the Global Weight Reduction Medicine Market
Based on product type, the prescription segment is anticipated to hold a prominent market share in the global weight reduction medicine market. The factors accelerating the growth of the segment include the large availability of therapeutically effective drugs available in the market which act on an immediate basis on the obesity problem. These drugs are mostly available with institutes that offer professional weight management program. These drugs are prescribed by weight management trainers who provide training programs. Health experts are also prescribing these drugs to consumers.
Regional Outlooks
The global weight reduction medicine market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). If we consider the geographic part, North America is anticipated to lead the weight reduction medicine market in the coming years.
Global Weight Reduction Medicine Market Growth, By Region 2022-2028
North America is estimated to Hold the Major Share in the Global weight reduction medicine Market
When the global weight reduction medicine market is analyzed as per the geographical segment, it is anticipated that the major share of the medicine market will be taken over by North America. The driving factor for the increase in market share in this region will be the adoption of obesity management programs such as Cleveland Clinic’s medical weight management programe. Major players in these regions are launching a new variety of weight reduction drugs suitable for consumers in every age group. They are spending a major chunk on the R&D segment of their company. For instance, in March 2021, Government of UK announced that it will be spending around 70 million euros in weight management services. This will help 70,000 adults to get rid of obesity and overweight.
Market Players Outlook
The major companies serving the global weight reduction medicine market include Novo Nordisk, Glaxo Smith Kline PLC, Vivus Pharmaceuticals, Currax Pharmaceuticals LLC, Pfizer Inc., and others. The market players are working in a consistent way to provide their consumers with healthy weight reduction options and medicines by adopting numerous market growth strategies such as new product launch, partnership collaboration, and others. For instance, in June 2021, FDA in US approved a drug named Wegovy, which can be used as a weight reduction medicine by health experts. This drug is a higher version of Novo Nordisk’s drug which they manufacture for diabetes.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global weight reduction medicine market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Weight Reduction Medicine Market
• Recovery Scenario of Weight Reduction Medicine Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Novo Nordisk
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Glaxo Smith Kline PLC
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Vivus LLC
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Currax Pharmaceuticals LLC
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Pfizer Inc.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Weight Reduction Medicine Market by Product Type
4.1.1. Prescription
4.1.2. Over the counter
4.2. Global Weight Reduction Medicine Market by Application
4.2.1. Appetite Suppression
4.2.2. Fat Blocking
4.2.3. Others
4.3. Global Weight Reduction Medicine Market by Distribution Channel
4.3.1. Hospital Pharmacies
4.3.2. Drug Store and Retail Pharmacies
4.3.3. Online Pharmacies
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. F. Hoffman-La Roche Ltd.
6.2. Abbott Laboratories
6.3. Cargill, Inc.
6.4. General Mills, Inc.
6.5. Ingredion, Inc.
6.6. Kellogg Company
6.7. Medifast, Inc.
6.8. Nutrisystem, Inc.
6.9. The Kraft Heinz Company
6.10. Pepsico, Inc.
6.11. Mondelez International
6.12. WW International, Inc.
6.13. Teva Pharmaceuticals Industries Ltd.
6.14. Novartis Healthcare Private Ltd.
6.15. Hexal AG
1. GLOBAL WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
2. GLOBAL WEIGHT REDUCTION MEDICINE BY PRESCRIPTION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL WEIGHT REDUCTION MEDICINE BY OVER THE COUNTER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
5. GLOBAL WEIGHT REDUCTION MEDICINE FOR APPETITE SUPPRESSION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL WEIGHT REDUCTION MEDICINE FOR FAT BLOCKING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL WEIGHT REDUCTION MEDICINE FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
9. GLOBAL WEIGHT REDUCTION MEDICINE IN HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL WEIGHT REDUCTION MEDICINE IN DRUG STORES AND RETAIL PHARMACIES IN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL WEIGHT REDUCTION MEDICINE IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14. NORTH AMERICAN WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
15. NORTH AMERICAN WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16. NORTH AMERICAN WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
17. EUROPEAN WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. EUROPEAN WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
19. EUROPEAN WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20. EUROPEAN WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. ASIA-PACIFIC WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS PRODUCT TYPE, 2021-2028 ($ MILLION)
23. ASIA-PACIFIC WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
25. REST OF THE WORLD WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
26. REST OF THE WORLD WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
27. REST OF THE WORLD WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
28. REST OF THE WORLD WEIGHT REDUCTION MEDICINE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL WEIGHT REDUCTION MEDICINE MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL WEIGHT REDUCTION MEDICINE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL WEIGHT REDUCTION MEDICINE MARKET, 2021-2028 (%)
4. GLOBAL WEIGHT REDUCTION MEDICINE MARKET SHARE BY PRODUCT TYPE, 2022 VS 2028 (%)
5. GLOBAL WEIGHT REDUCTION MEDICINE BY PRESCRIPTION MARKET SHARE BY GEOGRAPHY, 2022 VS 2028 (%)
6. GLOBAL WEIGHT REDUCTION MEDICINE BY OVER THE COUNTER MARKET SHARE BY GEOGRAPHY, 2022 VS 2028 (%)
7. GLOBAL WEIGHT REDUCTION MEDICINE MARKET SHARE BY APPLICATION, 2022 VS 2028 (%)
8. GLOBAL WEIGHT REDUCTION MEDICINE FOR APPETITE SUPPRESSION MARKET SHARE BY GEOGRAPHY, 2022 VS 2028 (%)
9. GLOBAL WEIGHT REDUCTION MEDICINE FOR FAT BLOCKING MARKET SHARE BY GEOGRAPHY, 2022 VS 2028 (%)
10. GLOBAL WEIGHT REDUCTION MEDICINE FOR OTHER APPLICATIONS MARKET SHARE BY GEOGRAPHY, 2022 VS 2028 (%)
11. GLOBAL WEIGHT REDUCTION MEDICINE MARKET SHARE BY DISTRIBUTION CHANNEL, 2022 VS 2028 (%)
12. GLOBAL WEIGHT REDUCTION MEDICINE IN HOSPITAL PHARMACY MARKET SHARE BY GEOGRAPHY, 2022 VS 2028 (%)
13. GLOBAL WEIGHT REDUCTION MEDICINE IN DRUG STORE AND RETAIL PHARMACY MARKET SHARE BY GEOGRAPHY, 2022 VS 2028 (%)
14. GLOBAL WEIGHT REDUCTION MEDICINE IN ONLINE PHARMACIES MARKET SHARE BY GEOGRAPHY, 2022 VS 2028 (%)
15. GLOBAL WEIGHT REDUCTION MEDICINE MARKET SHARE BY GEOGRAPHY, 2022 VS 2028 (%)
16. US WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
17. CANADA WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
18. UK WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
19. FRANCE WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
20. GERMANY WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
21. ITALY WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
22. SPAIN WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
23. REST OF EUROPE WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
24. INDIA WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
25. CHINA WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
26. JAPAN WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
27. SOUTH KOREA WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF ASIA-PACIFIC WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF THE WORLD WEIGHT REDUCTION MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
